You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › July › 21
Nordisk
4 days ago
Novo Nordisk, the maker of Wegovy and Ozempic, has launched legal action accusing its arch rival Eli Lilly of false advertising.
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising ⊖
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
Novo Nordisk accuses Eli Lilly of deceptive marketing in weight-loss fight ○
Danish group claims rival used outdated data to support claims that its products were more effective than Wegovy
page 1 of 1